今开:0.0 | 昨收:11.83 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:6.21202587E8 |
chuminhua2023-01-31 12:19
1月30日,FDA 宣布批准 Stemline Therapeutics $Stemline医疗(STML)$ 的 口服选择性雌激素受体降解剂(SERD)Orserdu(elacestrant)用于患有 ER+/HER2-、ESR1 突变的晚期或转移性乳腺癌且在至少一种内分泌治疗后疾病进展的绝经后女性或成年男性。 该机构去年给与该申请优先审评。网页链接查看全文
牛唐2020-01-16 21:55
研发类药企商业化任重道远,成功概率小,多半是好药在手,难以销售$Portola制药(PTLA)$ $Stemline医疗(STML)$ 就是这个道理。$欢聚时代(YY)$查看全文
$Stemline医疗(STML)$ 内部交易: 2020-05-04,Chief Commercial Officer,Francomano Robert ,卖出,272普通股, $11.51
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-057631 Size: 5 KB 网页链接
$Stemline医疗(STML)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0000895345-20-000618 Act: 34 Size: 36 KB 网页链接
$Stemline医疗(STML)$ SC14D9C Written communication relating to third party tender offer Accession Number: 0001104659-20-056147 Act: 34 Size: 103 KB 网页链接
$Stemline医疗(STML)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0000895345-20-000606 Act: 34 Size: 63 KB 网页链接
$Stemline医疗(STML)$ 8-K Current report, items 1.01, 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001104659-20-055854 Act: 34 Size: 1 MB 网页链接
$Stemline医疗(STML)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-20-053577 Act: 34 Size: 471 KB 网页链接
$Stemline医疗(STML)$ DEF 14A Other definitive proxy statements Accession Number: 0001047469-20-002716 Act: 34 Size: 1 MB 网页链接
$Stemline医疗(STML)$ 内部交易: 2020-04-15,CEO,Bergstein Ivan ,卖出,53618普通股, $4.88
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-048399 Size: 5 KB 网页链接